CN107183716A - A kind of liver protection is dispelled wine health-care food composition and preparation method thereof - Google Patents
A kind of liver protection is dispelled wine health-care food composition and preparation method thereof Download PDFInfo
- Publication number
- CN107183716A CN107183716A CN201710447203.9A CN201710447203A CN107183716A CN 107183716 A CN107183716 A CN 107183716A CN 201710447203 A CN201710447203 A CN 201710447203A CN 107183716 A CN107183716 A CN 107183716A
- Authority
- CN
- China
- Prior art keywords
- vitamin
- wine
- dispelled
- health
- food composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 210000004185 liver Anatomy 0.000 title claims abstract description 89
- 239000000203 mixture Substances 0.000 title claims abstract description 37
- 235000013305 food Nutrition 0.000 title claims abstract description 32
- 238000002360 preparation method Methods 0.000 title claims description 28
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 59
- 235000003145 Hippophae rhamnoides Nutrition 0.000 claims abstract description 49
- 241000237502 Ostreidae Species 0.000 claims abstract description 30
- 235000020636 oyster Nutrition 0.000 claims abstract description 30
- 235000019154 vitamin C Nutrition 0.000 claims abstract description 30
- 239000011718 vitamin C Substances 0.000 claims abstract description 30
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims abstract description 29
- 229930003268 Vitamin C Natural products 0.000 claims abstract description 29
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 claims abstract description 29
- 239000011726 vitamin B6 Substances 0.000 claims abstract description 22
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 claims abstract description 20
- 235000019158 vitamin B6 Nutrition 0.000 claims abstract description 20
- 229940011671 vitamin b6 Drugs 0.000 claims abstract description 20
- 239000002994 raw material Substances 0.000 claims abstract description 5
- 241000229143 Hippophae Species 0.000 claims description 57
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 30
- 235000013399 edible fruits Nutrition 0.000 claims description 18
- 239000000843 powder Substances 0.000 claims description 16
- 239000008213 purified water Substances 0.000 claims description 14
- 239000000047 product Substances 0.000 claims description 13
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 11
- 239000000284 extract Substances 0.000 claims description 10
- 239000007788 liquid Substances 0.000 claims description 10
- 235000003935 Hippophae Nutrition 0.000 claims description 9
- 239000012528 membrane Substances 0.000 claims description 9
- 238000010009 beating Methods 0.000 claims description 7
- 239000004033 plastic Substances 0.000 claims description 7
- 238000002156 mixing Methods 0.000 claims description 6
- 239000012141 concentrate Substances 0.000 claims description 5
- 238000011049 filling Methods 0.000 claims description 5
- 238000012856 packing Methods 0.000 claims description 5
- 239000010941 cobalt Substances 0.000 claims description 4
- 229910017052 cobalt Inorganic materials 0.000 claims description 4
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 claims description 4
- 239000002274 desiccant Substances 0.000 claims description 4
- 239000000706 filtrate Substances 0.000 claims description 4
- 238000001914 filtration Methods 0.000 claims description 4
- 239000012530 fluid Substances 0.000 claims description 4
- 239000012535 impurity Substances 0.000 claims description 4
- 230000002262 irrigation Effects 0.000 claims description 4
- 238000003973 irrigation Methods 0.000 claims description 4
- 235000013372 meat Nutrition 0.000 claims description 4
- 239000003595 mist Substances 0.000 claims description 4
- 238000005406 washing Methods 0.000 claims description 4
- 230000001954 sterilising effect Effects 0.000 claims description 3
- 238000004659 sterilization and disinfection Methods 0.000 claims description 3
- 238000007873 sieving Methods 0.000 claims description 2
- 239000002002 slurry Substances 0.000 claims description 2
- 238000001694 spray drying Methods 0.000 claims description 2
- 229910052782 aluminium Inorganic materials 0.000 claims 1
- 239000004576 sand Substances 0.000 claims 1
- 240000000950 Hippophae rhamnoides Species 0.000 abstract 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 46
- 230000000694 effects Effects 0.000 description 33
- 239000002775 capsule Substances 0.000 description 27
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 21
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 16
- 102000007698 Alcohol dehydrogenase Human genes 0.000 description 13
- 108010021809 Alcohol dehydrogenase Proteins 0.000 description 13
- 241000699670 Mus sp. Species 0.000 description 13
- 239000003814 drug Substances 0.000 description 13
- 229930003944 flavone Natural products 0.000 description 12
- 235000011949 flavones Nutrition 0.000 description 12
- 230000006870 function Effects 0.000 description 12
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 12
- 239000000243 solution Substances 0.000 description 12
- 210000004369 blood Anatomy 0.000 description 11
- 239000008280 blood Substances 0.000 description 11
- 238000000034 method Methods 0.000 description 11
- 230000008520 organization Effects 0.000 description 11
- 239000013641 positive control Substances 0.000 description 11
- 230000006378 damage Effects 0.000 description 8
- 235000019198 oils Nutrition 0.000 description 8
- 102000004190 Enzymes Human genes 0.000 description 7
- 108090000790 Enzymes Proteins 0.000 description 7
- 229940088598 enzyme Drugs 0.000 description 7
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 6
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 6
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 6
- 150000002212 flavone derivatives Chemical class 0.000 description 6
- 150000002213 flavones Chemical class 0.000 description 6
- 230000002440 hepatic effect Effects 0.000 description 6
- 102000004169 proteins and genes Human genes 0.000 description 6
- 108090000623 proteins and genes Proteins 0.000 description 6
- 230000009467 reduction Effects 0.000 description 6
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 6
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 6
- 208000007848 Alcoholism Diseases 0.000 description 5
- 229920002527 Glycogen Polymers 0.000 description 5
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 5
- 201000007930 alcohol dependence Diseases 0.000 description 5
- 230000037396 body weight Effects 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 238000003304 gavage Methods 0.000 description 5
- 229940096919 glycogen Drugs 0.000 description 5
- 150000002632 lipids Chemical class 0.000 description 5
- 210000005229 liver cell Anatomy 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 230000004060 metabolic process Effects 0.000 description 5
- 150000003254 radicals Chemical class 0.000 description 5
- 235000005493 rutin Nutrition 0.000 description 5
- 210000001519 tissue Anatomy 0.000 description 5
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 4
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- -1 carrotene Chemical compound 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 4
- 235000019197 fats Nutrition 0.000 description 4
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 4
- 238000007689 inspection Methods 0.000 description 4
- 229910052760 oxygen Inorganic materials 0.000 description 4
- 239000001301 oxygen Substances 0.000 description 4
- 230000035790 physiological processes and functions Effects 0.000 description 4
- 231100000572 poisoning Toxicity 0.000 description 4
- 230000000607 poisoning effect Effects 0.000 description 4
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 4
- 238000011084 recovery Methods 0.000 description 4
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 4
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 4
- 229960004555 rutoside Drugs 0.000 description 4
- 230000002000 scavenging effect Effects 0.000 description 4
- 210000002966 serum Anatomy 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 239000011573 trace mineral Substances 0.000 description 4
- 235000013619 trace mineral Nutrition 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 3
- 229930003427 Vitamin E Natural products 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 230000001154 acute effect Effects 0.000 description 3
- 238000003556 assay Methods 0.000 description 3
- VZGDMQKNWNREIO-UHFFFAOYSA-N carbon tetrachloride Substances ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 230000002708 enhancing effect Effects 0.000 description 3
- 230000002255 enzymatic effect Effects 0.000 description 3
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 235000012907 honey Nutrition 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 230000001965 increasing effect Effects 0.000 description 3
- 210000000936 intestine Anatomy 0.000 description 3
- 230000031700 light absorption Effects 0.000 description 3
- 229960002477 riboflavin Drugs 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 229960003080 taurine Drugs 0.000 description 3
- 210000003462 vein Anatomy 0.000 description 3
- 239000011716 vitamin B2 Substances 0.000 description 3
- 235000019165 vitamin E Nutrition 0.000 description 3
- 229940046009 vitamin E Drugs 0.000 description 3
- 239000011709 vitamin E Substances 0.000 description 3
- 239000011701 zinc Substances 0.000 description 3
- 229910052725 zinc Inorganic materials 0.000 description 3
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 241000972773 Aulopiformes Species 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 230000006820 DNA synthesis Effects 0.000 description 2
- 102000002322 Egg Proteins Human genes 0.000 description 2
- 108010000912 Egg Proteins Proteins 0.000 description 2
- 208000004930 Fatty Liver Diseases 0.000 description 2
- 206010019708 Hepatic steatosis Diseases 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 2
- 102000004316 Oxidoreductases Human genes 0.000 description 2
- 108090000854 Oxidoreductases Proteins 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- 208000034189 Sclerosis Diseases 0.000 description 2
- 241000209140 Triticum Species 0.000 description 2
- 235000021307 Triticum Nutrition 0.000 description 2
- 229930003471 Vitamin B2 Natural products 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 230000001476 alcoholic effect Effects 0.000 description 2
- 230000037354 amino acid metabolism Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 238000010241 blood sampling Methods 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 230000002279 cholagogic effect Effects 0.000 description 2
- 238000007405 data analysis Methods 0.000 description 2
- 230000003292 diminished effect Effects 0.000 description 2
- DVSZKTAMJJTWFG-UHFFFAOYSA-N docosa-2,4,6,8,10,12-hexaenoic acid Chemical compound CCCCCCCCCC=CC=CC=CC=CC=CC=CC(O)=O DVSZKTAMJJTWFG-UHFFFAOYSA-N 0.000 description 2
- MBMBGCFOFBJSGT-KUBAVDMBSA-N docosahexaenoic acid Natural products CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 description 2
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 230000035622 drinking Effects 0.000 description 2
- ZQPPMHVWECSIRJ-MDZDMXLPSA-N elaidic acid Chemical compound CCCCCCCC\C=C\CCCCCCCC(O)=O ZQPPMHVWECSIRJ-MDZDMXLPSA-N 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 208000010706 fatty liver disease Diseases 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 2
- 229960003180 glutathione Drugs 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 2
- IYRMWMYZSQPJKC-UHFFFAOYSA-N kaempferol Chemical compound C1=CC(O)=CC=C1C1=C(O)C(=O)C2=C(O)C=C(O)C=C2O1 IYRMWMYZSQPJKC-UHFFFAOYSA-N 0.000 description 2
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 2
- 230000003859 lipid peroxidation Effects 0.000 description 2
- 210000001589 microsome Anatomy 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 2
- BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 description 2
- 210000004681 ovum Anatomy 0.000 description 2
- SECPZKHBENQXJG-FPLPWBNLSA-N palmitoleic acid Chemical compound CCCCCC\C=C/CCCCCCCC(O)=O SECPZKHBENQXJG-FPLPWBNLSA-N 0.000 description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 238000001243 protein synthesis Methods 0.000 description 2
- 230000028527 righting reflex Effects 0.000 description 2
- 239000011435 rock Substances 0.000 description 2
- 235000019515 salmon Nutrition 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- 239000011265 semifinished product Substances 0.000 description 2
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 description 2
- 239000002689 soil Substances 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 231100000240 steatosis hepatitis Toxicity 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- 230000014616 translation Effects 0.000 description 2
- 238000005292 vacuum distillation Methods 0.000 description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 235000019156 vitamin B Nutrition 0.000 description 2
- 239000011720 vitamin B Substances 0.000 description 2
- 239000011715 vitamin B12 Substances 0.000 description 2
- 235000019164 vitamin B2 Nutrition 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 description 1
- SFLSHLFXELFNJZ-QMMMGPOBSA-N (-)-norepinephrine Chemical compound NC[C@H](O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-QMMMGPOBSA-N 0.000 description 1
- DWNBOPVKNPVNQG-LURJTMIESA-N (2s)-4-hydroxy-2-(propylamino)butanoic acid Chemical compound CCCN[C@H](C(O)=O)CCO DWNBOPVKNPVNQG-LURJTMIESA-N 0.000 description 1
- DNXIKVLOVZVMQF-UHFFFAOYSA-N (3beta,16beta,17alpha,18beta,20alpha)-17-hydroxy-11-methoxy-18-[(3,4,5-trimethoxybenzoyl)oxy]-yohimban-16-carboxylic acid, methyl ester Natural products C1C2CN3CCC(C4=CC=C(OC)C=C4N4)=C4C3CC2C(C(=O)OC)C(O)C1OC(=O)C1=CC(OC)=C(OC)C(OC)=C1 DNXIKVLOVZVMQF-UHFFFAOYSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- MGWGWNFMUOTEHG-UHFFFAOYSA-N 4-(3,5-dimethylphenyl)-1,3-thiazol-2-amine Chemical compound CC1=CC(C)=CC(C=2N=C(N)SC=2)=C1 MGWGWNFMUOTEHG-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- 108010082126 Alanine transaminase Proteins 0.000 description 1
- 208000022309 Alcoholic Liver disease Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 208000005623 Carcinogenesis Diseases 0.000 description 1
- 208000002177 Cataract Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 102000018832 Cytochromes Human genes 0.000 description 1
- 108010052832 Cytochromes Proteins 0.000 description 1
- 101710088194 Dehydrogenase Proteins 0.000 description 1
- UBSCDKPKWHYZNX-UHFFFAOYSA-N Demethoxycapillarisin Natural products C1=CC(O)=CC=C1OC1=CC(=O)C2=C(O)C=C(O)C=C2O1 UBSCDKPKWHYZNX-UHFFFAOYSA-N 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 206010021135 Hypovitaminosis Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- GQODBWLKUWYOFX-UHFFFAOYSA-N Isorhamnetin Natural products C1=C(O)C(C)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 GQODBWLKUWYOFX-UHFFFAOYSA-N 0.000 description 1
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 description 1
- FFFHZYDWPBMWHY-VKHMYHEASA-N L-homocysteine Chemical compound OC(=O)[C@@H](N)CCS FFFHZYDWPBMWHY-VKHMYHEASA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- 240000003915 Lophatherum gracile Species 0.000 description 1
- 102000008109 Mixed Function Oxygenases Human genes 0.000 description 1
- 108010074633 Mixed Function Oxygenases Proteins 0.000 description 1
- 102000010909 Monoamine Oxidase Human genes 0.000 description 1
- 108010062431 Monoamine oxidase Proteins 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- KEJOCWOXCDWNID-UHFFFAOYSA-N Nitrilooxonium Chemical class [O+]#N KEJOCWOXCDWNID-UHFFFAOYSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 235000021319 Palmitoleic acid Nutrition 0.000 description 1
- 102000057297 Pepsin A Human genes 0.000 description 1
- 108090000284 Pepsin A Proteins 0.000 description 1
- 102000003992 Peroxidases Human genes 0.000 description 1
- 235000014676 Phragmites communis Nutrition 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- LCQMZZCPPSWADO-UHFFFAOYSA-N Reserpilin Natural products COC(=O)C1COCC2CN3CCc4c([nH]c5cc(OC)c(OC)cc45)C3CC12 LCQMZZCPPSWADO-UHFFFAOYSA-N 0.000 description 1
- QEVHRUUCFGRFIF-SFWBKIHZSA-N Reserpine Natural products O=C(OC)[C@@H]1[C@H](OC)[C@H](OC(=O)c2cc(OC)c(OC)c(OC)c2)C[C@H]2[C@@H]1C[C@H]1N(C2)CCc2c3c([nH]c12)cc(OC)cc3 QEVHRUUCFGRFIF-SFWBKIHZSA-N 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 240000006394 Sorghum bicolor Species 0.000 description 1
- 235000011684 Sorghum saccharatum Nutrition 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 102000019197 Superoxide Dismutase Human genes 0.000 description 1
- 108010012715 Superoxide dismutase Proteins 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 241000256856 Vespidae Species 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 208000003056 Vitamin B6 deficiency Diseases 0.000 description 1
- 206010000059 abdominal discomfort Diseases 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- IKHGUXGNUITLKF-XPULMUKRSA-N acetaldehyde Chemical compound [14CH]([14CH3])=O IKHGUXGNUITLKF-XPULMUKRSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000002785 anti-thrombosis Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000000767 anti-ulcer Effects 0.000 description 1
- 239000003005 anticarcinogenic agent Substances 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 239000003907 antipyretic analgesic agent Substances 0.000 description 1
- 229940114079 arachidonic acid Drugs 0.000 description 1
- 235000021342 arachidonic acid Nutrition 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- HFACYLZERDEVSX-UHFFFAOYSA-N benzidine Chemical compound C1=CC(N)=CC=C1C1=CC=C(N)C=C1 HFACYLZERDEVSX-UHFFFAOYSA-N 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 230000008033 biological extinction Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 210000005252 bulbus oculi Anatomy 0.000 description 1
- 239000004067 bulking agent Substances 0.000 description 1
- 230000036952 cancer formation Effects 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 231100000504 carcinogenesis Toxicity 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 230000035603 choleresis Effects 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- SECPZKHBENQXJG-UHFFFAOYSA-N cis-palmitoleic acid Natural products CCCCCCC=CCCCCCCCC(O)=O SECPZKHBENQXJG-UHFFFAOYSA-N 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 230000007012 clinical effect Effects 0.000 description 1
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000000205 computational method Methods 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 235000020247 cow milk Nutrition 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 229960003067 cystine Drugs 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 238000006114 decarboxylation reaction Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 230000006806 disease prevention Effects 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- POULHZVOKOAJMA-UHFFFAOYSA-M dodecanoate Chemical compound CCCCCCCCCCCC([O-])=O POULHZVOKOAJMA-UHFFFAOYSA-M 0.000 description 1
- 229960003638 dopamine Drugs 0.000 description 1
- 231100000673 dose–response relationship Toxicity 0.000 description 1
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 210000002472 endoplasmic reticulum Anatomy 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 125000000816 ethylene group Chemical group [H]C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- 210000001508 eye Anatomy 0.000 description 1
- FPVGTPBMTFTMRT-NSKUCRDLSA-L fast yellow Chemical compound [Na+].[Na+].C1=C(S([O-])(=O)=O)C(N)=CC=C1\N=N\C1=CC=C(S([O-])(=O)=O)C=C1 FPVGTPBMTFTMRT-NSKUCRDLSA-L 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 229940014144 folate Drugs 0.000 description 1
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 229960003692 gamma aminobutyric acid Drugs 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 230000005176 gastrointestinal motility Effects 0.000 description 1
- 230000000762 glandular Effects 0.000 description 1
- 230000004110 gluconeogenesis Effects 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 244000144993 groups of animals Species 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- 230000002607 hemopoietic effect Effects 0.000 description 1
- 231100000753 hepatic injury Toxicity 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 235000020256 human milk Nutrition 0.000 description 1
- 210000004251 human milk Anatomy 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- SBHCLVQMTBWHCD-UHFFFAOYSA-N icosa-2,4,6,8,10-pentaenoic acid Chemical compound CCCCCCCCCC=CC=CC=CC=CC=CC(O)=O SBHCLVQMTBWHCD-UHFFFAOYSA-N 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 229960003284 iron Drugs 0.000 description 1
- 235000008800 isorhamnetin Nutrition 0.000 description 1
- IZQSVPBOUDKVDZ-UHFFFAOYSA-N isorhamnetin Chemical compound C1=C(O)C(OC)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 IZQSVPBOUDKVDZ-UHFFFAOYSA-N 0.000 description 1
- 235000008777 kaempferol Nutrition 0.000 description 1
- 208000006443 lactic acidosis Diseases 0.000 description 1
- 229940070765 laurate Drugs 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- OYHQOLUKZRVURQ-AVQMFFATSA-N linoelaidic acid Chemical compound CCCCC\C=C\C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-AVQMFFATSA-N 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- ZMKDEQUXYDZSNN-UHFFFAOYSA-N linolelaidic acid Natural products CCCCCCCCC=CCC=CCCCCC(O)=O ZMKDEQUXYDZSNN-UHFFFAOYSA-N 0.000 description 1
- 230000003212 lipotrophic effect Effects 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 210000002311 liver mitochondria Anatomy 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 210000005228 liver tissue Anatomy 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000037345 metabolism of vitamins Effects 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 description 1
- 230000003228 microsomal effect Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- UXOUKMQIEVGVLY-UHFFFAOYSA-N morin Natural products OC1=CC(O)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 UXOUKMQIEVGVLY-UHFFFAOYSA-N 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 150000005002 naphthylamines Chemical class 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- JCXJVPUVTGWSNB-UHFFFAOYSA-N nitrogen dioxide Inorganic materials O=[N]=O JCXJVPUVTGWSNB-UHFFFAOYSA-N 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- SFLSHLFXELFNJZ-UHFFFAOYSA-N norepinephrine Natural products NCC(O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-UHFFFAOYSA-N 0.000 description 1
- 229960002748 norepinephrine Drugs 0.000 description 1
- 210000003924 normoblast Anatomy 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000003992 organochlorine insecticide Substances 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 230000004783 oxidative metabolism Effects 0.000 description 1
- 229960005489 paracetamol Drugs 0.000 description 1
- 238000010827 pathological analysis Methods 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 229940111202 pepsin Drugs 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- 238000005502 peroxidation Methods 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 150000003906 phosphoinositides Chemical class 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- NGVDGCNFYWLIFO-UHFFFAOYSA-N pyridoxal 5'-phosphate Chemical group CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O NGVDGCNFYWLIFO-UHFFFAOYSA-N 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000006479 redox reaction Methods 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- BJOIZNZVOZKDIG-MDEJGZGSSA-N reserpine Chemical compound O([C@H]1[C@@H]([C@H]([C@H]2C[C@@H]3C4=C([C]5C=CC(OC)=CC5=N4)CCN3C[C@H]2C1)C(=O)OC)OC)C(=O)C1=CC(OC)=C(OC)C(OC)=C1 BJOIZNZVOZKDIG-MDEJGZGSSA-N 0.000 description 1
- 229960003147 reserpine Drugs 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- MDMGHDFNKNZPAU-UHFFFAOYSA-N roserpine Natural products C1C2CN3CCC(C4=CC=C(OC)C=C4N4)=C4C3CC2C(OC(C)=O)C(OC)C1OC(=O)C1=CC(OC)=C(OC)C(OC)=C1 MDMGHDFNKNZPAU-UHFFFAOYSA-N 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229940076279 serotonin Drugs 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 210000000329 smooth muscle myocyte Anatomy 0.000 description 1
- FQENQNTWSFEDLI-UHFFFAOYSA-J sodium diphosphate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])([O-])=O FQENQNTWSFEDLI-UHFFFAOYSA-J 0.000 description 1
- 229940048086 sodium pyrophosphate Drugs 0.000 description 1
- 238000007711 solidification Methods 0.000 description 1
- 230000008023 solidification Effects 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000002798 spectrophotometry method Methods 0.000 description 1
- 235000015096 spirit Nutrition 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 238000005987 sulfurization reaction Methods 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- 125000000383 tetramethylene group Chemical group [H]C([H])([*:1])C([H])([H])C([H])([H])C([H])([H])[*:2] 0.000 description 1
- 235000019818 tetrasodium diphosphate Nutrition 0.000 description 1
- 239000001577 tetrasodium phosphonato phosphate Substances 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100001265 toxicological assessment Toxicity 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 230000036269 ulceration Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 210000003934 vacuole Anatomy 0.000 description 1
- 208000019553 vascular disease Diseases 0.000 description 1
- 210000004509 vascular smooth muscle cell Anatomy 0.000 description 1
- 230000001018 virulence Effects 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 229940046001 vitamin b complex Drugs 0.000 description 1
- 230000002618 waking effect Effects 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 238000013389 whole blood assay Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4415—Pyridoxine, i.e. Vitamin B6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Botany (AREA)
- Zoology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Marine Sciences & Fisheries (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention provides a kind of health-care food composition for wine of being dispelled for liver protection, include the raw material of following parts by weight:Oyster:25 40 parts, sea-buckthorn:40 60 parts, vitamin C:20 30 parts, vitamin B6:0.01 1.5 parts.
Description
Technical field
The present invention relates to food, field of health care products, more particularly to liver protection dispel wine health-care food composition and its preparation side
Method.
Background technology
China, which is one, has the country of deep spirits culture, and wine turns into national and carries out the indispensable work of social activities already
Tool.Alcohol absorbs from intestines and stomach quickly enters blood, 100% can be absorbed in two hours.Liver is the main of metabolism alcohol
Organ, the alcohol dehydrogenase (ADH) that alcohol passes through in liver is catalyzed and generates acetaldehyde, and acetaldehyde takes off through the acetaldehyde in liver mitochondrion
Hydrogen enzyme (ALDH) is further oxidized to nontoxic acetic acid, ultimately generates carbon dioxide and energy.
However, the speed of liver oxidative metabolism alcohol is very slow, heavy drinking can cause the concentration of alcohol in blood drastically to rise
Height, causes acute alcoholism i.e. drunk.After acute alcoholism, the discomfort of long period can be caused, the long period occur
Headache, dizzy, insomnia, it is weak, tremble, have a stomach upset and nausea, or even show as hyponea.Long-term excessive consumption of alcohol, liver
Easily accumulate poisoning, cause stem cell alcohol to be denatured, and then develop into fatty liver, hepatic sclerosis even liver cancer.Alcoholic liver
Infringement has become one of main reason of chemical damage.
At present, product of sobering up on the market is with natural honey main material mostly.However, honey sober up effect itself has
Limit, effect is not good enough, and supply falls short of demand for natural honey in addition, expensive, is not suitable for the demand of industrialization.Other some other solution
Wine liver-protecting medicine, main component is based on flower of Radix Puerariae, radix glycyrrhizae, lophatherum gracile, kuh-seng, and curative effect is simultaneously imprecise.
The content of the invention
Dispelled the health-care food composition of wine for liver protection it is an object of the invention to provide a kind of, including following parts by weight
Raw material:Oyster:25-40 parts, sea-buckthorn:40-60 parts, vitamin C:20-30 parts, vitamin B6:0.01-1.5 parts.
Preferably, the oyster is 30-35 parts;The sea-buckthorn is 42-58 parts;The vitamin C is 22-28 parts, dimension life
Plain B6 is 0.01-1.5 parts.
Preferably, the oyster is 32 parts;The sea-buckthorn is 45 parts;The vitamin C is 22.8 parts;Vitamin B6 is
0.2 part.
It is an object of the invention to provide it is a kind of for liver protection dispel wine health-care food composition preparation method, including under
Row step:
(1) fructus hippophae is gone into the removal of impurity, cleaned up, remove its carpopodium flower base of a fruit, add water, crushing and beating is husky by gained
The extruding of spine pulp takes juice and filters off residue, and gained juice is dried after filtering and concentrating, and seabuckthorn fruit powder is made;
(2) fresh and alive oyster is taken, broken shell takes full oyster meat, directly or is put into pressure cooker and boils after washing, filter, obtain milky white
Color extract solution, then, equivalent pure water is added into residue, about 30min is boiled again, and after being filtered, this filtrate is carried with original
Take liquid to mix, then extract solution is evaporated in vacuo, the sticky russet flow fluid that moisture is 67.34% is obtained, by the concentrate
Wink-dry is carried out, uniformly light yellow micro mist is obtained;
(3) vitamin C is taken;
(4) vitamin B6 is taken;
(5) above-mentioned four kinds of raw materials are loaded in mixing machine according to the above ratio, fully mixed, the irradiation of cobalt 1 is gone out after pack
Bacterium, kept dry.
(6) prepared by finished product:
No. 1 mechanical irrigation preparation shell is selected, filling with preparation bottle placer, 0.3 gram/is aluminum-plastic packaged again using aluminum-plastic packaged
Plate, with being fitted into polybag, finally adds outer packing, finished product is made with small desiccant bag.
Preferably, water described in the step (1) is purified water, and the weight of the purified water is 2-5 times of fructus hippophae;Institute
The temperature for stating purified water is 50-70 DEG C.
Preferably, water described in the step (1) is purified water, and the weight of the purified water is 3 times of fructus hippophae;It is described
The temperature of purified water is 60 DEG C.
Preferably, crushing and beating described in the step (1) uses the beater that screen-aperture is 0.6-1.0 millimeters;Institute
It is powdered to state the vitamin C in step (3).
Preferably, filter membrane used is 0.1-0.5 μm of filter membrane in the step (2);Milipore filter used is that cutoff amount is
3500-6500 milipore filter.
Preferably, filter membrane used is 0.2 μm of filter membrane in the step (2);Milipore filter used is that cutoff amount is 5000
Milipore filter.
Preferably, crushing and beating described in the step (1) uses the beater that screen-aperture is 0.8 millimeter;The step
Suddenly sieving sieve used is 200 mesh in (2).
It should be appreciated that foregoing description substantially and follow-up description in detail are exemplary illustration and explanation, should not
As the limitation to claimed content of the invention.
Brief description of the drawings
With reference to the accompanying drawing enclosed, the present invention more purpose, function and advantages will pass through the as follows of embodiment of the present invention
Description is illustrated, wherein:
Fig. 1 shows blank control group mouse liver organization chart;
Fig. 2 shows positive controls mouse liver organization chart;
Fig. 3 shows that liver protection is dispelled wine low dose group mouse liver organization chart;
Fig. 4 shows that liver protection is dispelled wine middle dose group mouse liver organization chart;
Fig. 5 shows that liver protection is dispelled wine high dose group mouse liver organization chart.
Embodiment
By reference to one exemplary embodiment, the purpose of the present invention and function and the side for realizing these purposes and function
Method will be illustrated.However, the present invention is not limited to one exemplary embodiment as disclosed below;Can by multi-form come
It is realized.The essence of specification is only to aid in the detail of the various equivalent modifications Integrated Understanding present invention.
Hereinafter, embodiments of the invention will be described with reference to the drawings.In the accompanying drawings, identical reference represents identical
Or similar part, or same or like step.
Dispelled the invention provides a kind of liver protection the health-care food composition of wine, affiliated preparation includes following compositions:Oyster
25-40 parts, 40-60 parts of sea-buckthorn, 0-30 parts of Catergen, vitamin B60.01-1.5 parts (usage amount is micro, and every 100 grams total
Vitamin B in medicinal powder6Content be 200 milligrams).Each efficacy of drugs that these drug regimens are is produced into synergy, reached
The purpose of relieving alcoholism and protecting liver.
Wherein sea-buckthorn is by sea buckthorn fruit powder, sea buckthorn fruit Quercetin containing flavonoid, Isorhamnetin, kaempferol
And its glycosides, and containing vitamin C, vitamin E, carrotene, vitamin B1, vitamin B2, vitamin B6, vitamin B12And leaf
Acid;Institute's fatty acids have myristic acid, palmitoleic acid, palmitic acid, stearic acid and oleic acid, linoleic acid, elaidic acid, linolelaidic acid,
Arachidonic acid, laurate etc.;Additionally contain a variety of organic acids, saponin(e, sterol, carbohydrate and 15 kinds of trace elements.
Sea-buckthorn has following physiological function:
(1) protection liver and digestive system
20% g kg of sea buckthorn juice 0.84 and 1.68 g kg body weight are to CCL4, paracetamol induced mice damage
Increasing for MDA (MDA) has obvious inhibiting effect in liver, and can significantly reduce CCL4The SGPT vigor of poisoning mice, confrontation is flutterred
The exhaustion of heat breath pain poisoning mice liver glutathione (GSH).The g kg of Seabuckthorm Seed Oil 0.25 and 0.5 g kg weight gavage, can
Significantly reduce CCL4Necrosis region in the liver caused.Electron microscopic observation, CCL4Group rough surfaced endoplasmic reticulum (RER) changes, i.e., small in liver cytoplasm
Sheet basophilla material largely disappears, and Seabuckthorn Oil can be such that the material recovers to normal level.Seabuckthorn Oil can be also resisted by CCL4
The dysbolisms such as metabolism, sugar synthesis, glycogen solidification, the protein synthesis of caused liver cell.Seabuckthorn Oil can prevent liver thin
Born of the same parents P450 reduction, prevented also from the reduction of total protein in liver and water-solubility protein, and by ethanol and CCl4The cell risen
Matter and microsome, the reduction of hepatic protein.In addition, Seabuckthorn Oil intraperitoneal injection has lipotropic effect, and it is chloro- to 3,4-
The liver plasma membrane of 1- butylene slow poisoning rats has stabilization.
Neutral lipid composition in Seabuckthorn Oil and seabuckthorn fruit powder has very strong antiulcer action, has to reserpine institute Ulceration
Notable antagonism.The healing of gastric ulcer and damage of intestines can be accelerated, stomach lining MDA is reduced and improve neutral amino
The concentration of acid.In addition, Seabuckthorn Oil and seabuckthorn fruit powder can make animal saliva and stomach and intestine glandular secretion increase, pepsin content rise.
There are stimulation, Rythmic contractions characteristic cycle stretch-out, amplitude increase to gastrointestinal motility function simultaneously.
(2) free radical is removed
Stimulate polymorphonuclear human leukocytes (PMN) raw PMA when containing 1.7 milligrams of total seabuckthorn flavones in every milliliter of sea-buckthorn solution
Into active oxygen radical have obvious scavenging action, when containing 0.03-3 milligram total seabuckthorn flavones in every liter of sea-buckthorn solution to yellow fast
The active oxygen radical of purine/Huang Piao Ling oxidase systems has the scavenging action of notable dose dependent, but riboflavin is produced
The scavenging action of liveliness proof oxygen radical is weaker.Fenton is reacted when containing the milligram hour of total seabuckthorn flavone 3 in every liter of sea-buckthorn solution
The HO of generation has obvious scavenging action, and multinuclear people can also be significantly inhibited when containing 1 milligram of total seabuckthorn flavone in every liter of sea-buckthorn solution
The luminescent activity that leucocyte is produced.
Mouse is injected intraperitoneally the mg/kg body weight of Seabuckthorn Oil 2.5, Wheat Protein and prevents fatty liver from making
With, and lipid peroxidation speed and Vitamin E levels in tissue can be adjusted.Seabuckthorn Oil is similar to vitamin E, and Hyperlipidemic Serum is damaged
The vascular smooth muscle cells of wound have protective effect, can substantially reduce elevated MDA in high fat damage smooth muscle cell
(LOP) content, and SOD activity can be significantly improved, so as to mitigate damage of the Hyperlipidemic Serum to cell membrane, protect and promote thin
The healthy growth of born of the same parents.
(3) it is antifatigue and other
Seabuckthorn fruit powder is rich in vitamin C and various trace elements, has desirable influence to dispelling fatigue and enhancing locomitivity,
It also can significantly improve cardiac function.The mg/kg body weight of mouse peritoneal injection total seabuckthorn flavone 2, continuous 6 days, body weight had a net increase of
Plus apparently higher than control group.
Heavy dose of sea-buckthorn concentrate can be obviously prolonged the time of yellow Jackets induced mice sleep.Seabuckthorm Seed Oil can show
Write the activity for suppressing monoamine oxidase in mouse brain.
Other sea-buckthorn also has enhancing immune, improves cardiovascular system and hemopoietic system function, and anti-tumor radiation
With the function such as anti-inflammatory.The seabuckthorn fruit powder that the present invention is used is prepared using vanguard technology, effectively saves sea-buckthorn
Contained all functional components in fruit, therefore possess various functions described above.
The physiological function of oyster:
Oyster is rare Hai Zhen, its not only delicious flavour, and nourishing health function also to be spoken approvingly of at all times.Oyster is rich in
The mineral matter such as vitamin B complex, inositol, choline and zinc, iron.
Oyster is many to the benefit of human body:
(1) trace element such as mineral matter selenium, zinc that oyster is rich in can promote the immunologic function of body, preventing cold, in addition
Zinc can promote the synthesis of protein, thus with enhancing muscle power, recreative effect.
(2) oyster contains more than 20% good protein, and its amino acid composition is perfect, more than cow's milk and human milk.
(3) it is generally composite phospholipid, phosphoinositide, eicosapentenoic acid with physiologically active though oyster is few containing lipid
(EPA), docosahexenoic acid (DHA) etc..These compositions prevent artery sclerosis, antithrombotic and anti-aging effects.
(4) oyster is rich in natural taurine.Taurine has eliminating inflammation and expelling toxin, hepatic cholagogic, reducing blood lipid, promotion child brain hair
Educate and the effect such as mind-tranquilizing brain-strengthening, its effect is embodied in:
1) hepatic cholagogic, promotes liver function, improves the function of detoxification of liver;
2) lactic acidosis, relaxing smooth muscle, dispelling fatigue are promoted;
3) choleresis, the emulsification of fat, reducing blood lipid are promoted;
4) anti-inflammatory, antipyretic analgesic;
5) alcohol virulence is suppressed.
6) sugared part contained by oyster is that glycogen accounts for 20-40% in glycogen, its extract.Glycogen is the deposit of tissue energy substance
Form, is the material guarantee of physical mental activity efficiency and endurance.
Ascorbic physiological function:
(1) redox
In vivo, vitamin C/DHVC redox reaction and sulfydryl (- SH)/cystine linkage (- S-S) system
It is associated.Therefore vitamin C can improve in vivo-SH levels.Vitamin C may play the role of to remove free radical in vivo, have
A little infringements of the chemical substance to body, are directed to the effect of free radical, such as oxygen, ozone, nitrogen dioxide, alcohol, carbon tetrachloride
And damage of the Aclacnomycin A Hydrochloride in anticarcinogen to heart.Vitamin C can resist as internal water miscible antioxidant with fat-soluble
Oxidant has synergy, may be played a role on lipid peroxidation is prevented, crystal of human eye in the presence of light,
Also O can be produced2Free radical, may be cataract Producing reason.These free radicals are under normal circumstances to be anti-oxidant in vivo
Agent such as vitamin C, the sweet peptide of wheat Guang are removed, so substantial amounts of vitamin C can prevent the destruction of this peroxidation.
(2) Vitamin C effect some drugses are metabolized
1. influence of the vitamin C to hepatomicrosome enzyme system;Some fat-soluble medicines under hepatomicrosome enzyme systemic effect,
Carry out carboxylated and remove four bases, after polar compound, it is easy to removing toxic substances is discharged from bile and urine.Organochlorine insecticide energy
Microsomal enzyme vigor is sent out thoroughly.But this enzyme system reacts sharper to vitamin situation.The degree of hypovitaminosis C is not yet
When reaching Body weight loss, the vigor of hydroxylase system has declined in microsome, wherein with the reduction of cytochrome reductase most
It is many, about subtract 85%, after replenishing vitamins C, vitamin C amount recovers normal within a short period of time in tissue, but enzyme activity recover compared with
Slowly.
2. vitamin C, which also has, goes histamine to act on and prevent the carcinogenesis of benzidine, naphthylamines and nitrosonium salts.
The physiological function of vitamin B6:
It is main to participate in nearly hundred kinds of enzyme reactions in phosphoric acid Vitamin B6 (PLP) form.It is most relevant with amino acid metabolism:Including turning
Amino, decarboxylation, side chain cleavage, it is dehydrated and turns sulfurization.These biochemical functions are related to many-side.
1st, protein synthesis and catabolism are participated in, all amino acid metabolisms are participated in, it is relevant such as with the metabolism of ferroheme, with
Tryptophan synthesis nicotinic acid is relevant.
2nd, gluconeogenesis, UFA metabolism are participated in.Metabolism with glycogen, sphingomyelin and steroids is relevant.
3rd, some neurotransmitters (serotonin, taurine, dopamine, norepinephrine and γ-aminobutyric acid) are participated in
Synthesis.
4th, the metabolism of vitamin B6 and one carbon unit, vitamin B12 and folate, if their dysbolisms can cause huge
Normoblast anaemia.
5th, nucleic acid and DNA synthesis are participated in, shortage can damage DNA synthesis, and this process is to maintaining suitable immunologic function
It is very important.
6th, the relation of vitamin B6 and vitamin B2 is very close, and Vitamin B6 deficiency is often accompanied by vitamin B2 symptom.
7th, conversion of the homocysteine to methionine is participated in, the effect with reduction chronic disease, the slight high Guang of homotype half
Propylhomoserin mass formed by blood stasis is considered as a kind of potentially dangerous factor of vascular diseases, and the intervention of vitamin B6 can reduce the Guang ammonia of blood plasma homotype half
Acid content.
The preparation process of the relieving alcoholism and protecting liver preparation of the present invention is as follows:
(1) preparation of seabuckthorn fruit powder:
Choose fresh, good, full maturity, in orange-yellow or salmon pink fructus hippophae, the branch that artificial removal is wherein mingled with
The impurity such as leaf soil rock, are cleaned up with clear water, wash away the silt adhered to thereon, worm's ovum etc., and the sea-buckthorn cleaned up is through repairing
Whole its carpopodium of removal flower base of a fruit etc., adds the purified water that 2-5 times of weight is 50-70X, equably sends into beater and carries out broken beat
Slurry, the screen-aperture of beater should carry out extruding with the juice extractor of spiral 20 and take juice in 0.6-1.0 millimeters, gained sea-buckthorn pulp
And filter off residue, after filtering and concentrating, using vacuum and low temperature spray drying process, seabuckthorn fruit powder is made in extruding gained juice.
(2) preparation of oyster:
Fresh and alive oyster is taken, broken shell takes full oyster meat, directly or after washing be put into pressure cooker (pressure is 98kPa), plus etc.
Ratio pure water (weight ratio), boils about 30min under 98kPa pressure, recovers after normal pressure, is filtered under diminished pressure with filter paper, obtains milky white
Color extract solution.
Then, add equivalent pure water again into residue, about 30min is boiled, after being filtered, by this filtrate and original extraction
Liquid is mixed, then extract solution is carried out into vacuum (0.133-0.66kPa, 70-80 DEG C of temperature) distilled, obtain moisture for 67.34% it is viscous
Thick russet flow fluid, liquid color compared with before vacuum distillation is light.The concentrate is utilized into common spray dried form (wink
Between hot blast temperature be 180 DEG C, outlet temperature be 80 DEG C, speed of dripping be 30mL per minute) carry out wink-dry, obtain uniformly shallow
Yellow micro mist is stand-by.
(3) vitamin C.
(4) vitamin B6.
(5) prepared by semi-finished product:
Above-mentioned four kinds of bulk drugs are loaded in mixing machine according to the above ratio, fully mixed, the irradiation sterilization of cobalt 1 after pack
(5KGY), kept dry.
(6) prepared by finished product:
No. 1 mechanical irrigation preparation shell is selected, filling with preparation bottle placer, 0.3 gram/is aluminum-plastic packaged again using aluminum-plastic packaged
Plate, with being fitted into polybag, finally adds outer packing, finished product is made with small desiccant bag.
The need for according to preparation, it can be assigned in health-care food composition of the present invention containing the medicine commonly used in medicament word field
Shape punishment, for example,
Solvent, filler, flavor enhancement, disintegrant, adhesive, lubricant, wetting agent, pigment, bulking agent, diluent, increasing
Thick dose etc., any conventional peroral dosage form, such as pill, powder, tablet, capsule are prepared into conventional method of Chinese medicinal
Agent, oral liquid etc..The present invention is that capsule (is hereinafter referred to as the dispel preferred dosage form of health-care food composition of wine of liver protection
Liver-protecting capsule).
The present invention has effects that obvious relieving alcoholism and protecting liver for the dispel health-care food composition of wine of liver protection, wine of dispelling nourishing
Effect.
The present invention dispels for liver protection, and one time a day for day usual amounts for the instructions of taking of health-care food composition of wine, and every time 3
Grain.
The present invention can substantially increase the activity of internal alcohol dehydrogenase for the dispel health-care food composition of wine of liver protection, have
There is preferable antialcoholism function.Pharmacological evaluation shows, take for liver protection dispel wine health-care food composition mouse continuously to
After wine 15 days, the more normal mouse liver cell of liver cell is without significant change, and the health-care food composition of unused wine of being dispelled for liver protection
Mouse continuously to wine after 15 days, then there is obvious alcohol sample lesion in liver cell, illustrates that this is used for liver protection and dispelled the health care food of wine
Product composition liver protection effect is obvious.This is used for the dispel health-care food composition of wine of liver protection and entered in Beijing Disease Prevention and Control Centre
The experiments such as toxicological assessment, healthcare function evaluation, effective component identification, stability and hygiene inspection are gone, have owned
Index reaches examination requirements.Human experimentation also shows that the drug regimen can increase the activity of alcohol dehydrogenase to Alcoholic
Hepatic injury has significant protective effect.
Be expanded on further below by way of test example it is of the present invention for liver protection dispel wine health-care food composition it is (following
Abbreviation liver-protecting capsule) beneficial effect, these test examples include the present invention and are dispelled for liver protection the health-care food composition of wine
Pharmacodynamics test and clinical effect trial.
The method of inspection of functional component, content and functional component is described below
1. functional component
Seabuckthorn fruit powder main composition is general flavone, and oyster main composition is trace element, therefore is detected in product
General flavone, ascorbic content, you can reach the purpose of control product quality.
2. content:
Flavones (milligram/100 gram) 310
Vitamin C (gram/100 grams) 20
Vitamin B6 (milligram/100 gram) 10
3. the method for inspection:
3.1 Vitamin C contents are determined:
Meet " Pharmacopoeia of People's Republic of China ", the general provision of version in 2015.
The assay method of 3.2 general flavones
3.2.1 the preparation of rutin standard liquid
0.0210g rutins standard items are accurately weighed in 100mL volumetric flasks plus methanol dissolves and is settled to scale and shakes up again
Accurate point takes the 5mL solution to be shaken up in 50mL volumetric flasks with methanol dilution to scale.
3.2.2 the foundation of standard curve
It is accurate draw rutin standard liquid 0.00mL, 1.00mL, 2.00mL, 3.00mL, 4.00mL, 5.00mL, 6.00mL,
7.00mL is in magnetic evaporating dish plus 1g Silons are adsorbed in 85 DEG C of water-baths and fling to methanol, is then transferred to chromatographic column and is washed with methanol
Add methanol constant volume to scale to shake up after taking off flavones into 25mL colorimetric cylinders and light absorption value is determined at 360nm wavelength with the micro- of rutin
Gram quantity is that abscissa light absorption value is that ordinate does standard curve.
Regression equation Y=5.841667E-04+7.889331E-04*X, coefficient R=0.999246.
3.2.3 assay method
5mL health-care tea beverages are accurately pipetted in magnetic evaporating dish plus 1g Silons are adsorbed in 85 DEG C of water-baths and fling to moisture
Then be transferred on chromatographic column with methanol elute flavones into 25mL colorimetric cylinders after shaken up with methanol constant volume to scale this liquid in
Light absorption value is determined at 360nm according to the content of the general flavone from the rutin Microgram calculating sample checked on standard curve (with reed
Fourth meter).
The measure of 3.3 vitamin B6s:
Vitamin B6 standard:Defer to " Pharmacopoeia of People's Republic of China ", version in 2015, it is adaptable to medicine, food and feed
Detection regulation.
Embodiment 1 activates the experiment in vitro of alcohol dehydrogenase:
Alcohol dehydrogenase activity assay method:A Huo He (vaell&Hoch) method is strangled using watt, and is slightly detected after improvement
Alcohol dehydrogenase activity.Sodium pyrophosphate buffer solution 1.5ml is added in pipe is determined, after mixing at 25 DEG C, capping incubates 5mn.
Measure pipe after incubation adds alcohol dehydrogenase 0.lml immediately, uses spectrophotometric determination absorbance (A340) after shaking up immediately
Value, later reading every 10s once, METHOD FOR CONTINUOUS DETERMINATION 5mn.Zero point is set up with control tube, the reaction of health-care food composition is not added with
Group is the blank control group for determining alcohol dehydrogenase activity.
Alcohol dehydrogenase activity computational methods:It is plotted against time with A, negates and answer initial linear segment, calculates A340nm/
10s value added, is 6.2 according to molar extinction coefficients of the NADH at 340nm, calculates the unit of activity of enzyme.ADH activity with
The nanomole number of NADH generations per minute is represented.
(activation) rate of suppression is calculated:
(activation) rate of suppression (%)={ enzymatic activity is without the enzymatic activity dosing measure group of medicine control group one }/enzymatic activity is compareed without medicine
Group x100%
Above-mentioned every kind of Chinese medicine experiment is repeated 3 times, and is surveyed experimental data and is represented with x scholar s, is examined using t and carry out statistics
Analysis
As a result:
The result of table 1 shows that low dosage liver protection wine capsule, middle dosage liver protection wine capsule, high dose liver protection wine capsule of dispelling of dispelling of dispelling is equal
Alcohol dehydrogenase activity is improved, activity ratio is respectively 12.75%, 15.12%, 16.33%, illustrate that liver protection wine capsule of dispelling has
The effect of alcohol dehydrogenase activity is activated, and dosage more high ethano dehydrogenase activity ratio is higher.
The liver protection of embodiment 2 is dispelled wine zoopery
Animal packet:Mouse is randomly divided into six groups, every group 8, male and female half and half, wherein 5 groups are made acute alcoholic liver damage
Wound model:I.e. positive controls, sobering-up liver-protecting capsule group, are administered low dose group, middle dose group, high dose group;Separately set blank pair
According to group.Water 6h is can't help in fasting before modeling and dosage, 5 groups of animal gavages in addition to blank control group, and mouse presses 0.14m/10g
Gavage strong, colourless liquor distilled from sorghum;After 20min, by basic, normal, high dosage, (0.15g/kg, 0.3g/kg, 0.45g/kg are respectively administration group mouse
Be grown up daily consumption 5,10,15 times) gavage sobering-up liver-protecting capsule;Positive controls gavage same volume physiological saline;Blank control
Group is normal to raise;Successive administration 30d.
Experimental implementation:Experiment is filled in first time daily starts timing after drinking, records drunk and number of animals of sobering up (with for the moment
In), calculate rate of sobering up and liquor-saturated ratio of waking up;Occur the righting reflex positive be considered as it is drunk (animal foot is lain on the back in platform upwards,
30s voluntarily can not climb over body, and person is the positive, otherwise is feminine gender), righting reflex feminine gender, which is considered as, sobers up.Drunk time and when sobering up
Between be designated as tolerance time and recovery time respectively, the situation of change of an each group mouse weight is recorded weekly, mouse is surveyed after 30d
The SOD values of LPO values and whole blood;Before experiment, fasting 12 hours extracts eyeball blood sampling, detects the LPO values of serum and the SOD of whole blood
Value, puts to death mouse after blood sampling, takes mouse liver to do pathological section.
The LPO of mice serum, the SOD values of whole blood assay method:Lipid peroxidase (LPO), superoxide dismutase
Enzyme (SOD) method as defined in its kit is operated.
Hepatic tissue pathology sections observation:Hepatic tissue is taken pictures by doing microscope inspection observation after section.
As a result represent and data analysis:Data analysis is carried out using SPSS11.0 softwares.
As a result it is as follows:
Influence of the wine capsule to mouse weight 1. liver protection is dispelled
1-2 weeks changes of weight result of each experimental mice of table 2
Note:Compared * * with blank control group and represent P<0.01* represents P<0.05
3-4 weeks changes of weight result of each experimental mice of table 3
Note:Compared * * with blank control group and represent P<0.01* represents P<0.05
Table 2, the result of each experimental mice changes of weight of table 3 show, the changes of weight phase with blank control group mouse
Than during raising 30 days, the change of other groups of mouse is less than normal, compared with positive controls mouse, takes liver protection and dispels wine capsule
Mouse weight tends to be normal.
Influence of the wine capsule to mouse alcohol tolerance time and recovery time 2. liver protection is dispelled
Each model group mouse alcohol tolerance time of table 4 and recovery time result
Note:Compared * * with positive controls and represent P<0.01
From upper table 4, compared with positive controls, take liver protection dispel wine Capsules group mouse alcohol tolerance time it is obvious
Lengthen, recovery time substantially shortens, there were significant differences, wherein the effect of middle high dose group is more preferable.
Influence of the wine capsule to mice drunk rate 3. liver protection is dispelled
Drunk result of each model group mouse of table 5 in same time
As a result show, within a certain period of time, the drunk rate of positive controls mouse is 100%, and liver protection is dispelled the liquor-saturated of wine Capsules group
Rate is substantially reduced, wherein the middle drunk rate of high dose group mouse is lower, points out a certain amount of liver protection wine capsule of dispelling effectively to drop
The drunk rate of low mouse.
Influence of the wine capsule to mouse liver LPO values 4. liver protection is dispelled
Each experimental mice liver homogenate LPO values of table 5
Note:Compared with blank control group, * represents P<0.05
As a result show, compared with blank control group, other each group Mouse Liver LPO values rises compared with positive controls, are given
The LPO values of medicine each group are substantially reduced, wherein the reduction of middle high dose group is more notable, illustrate that liver protection wine capsule of dispelling can effectively reduce small
Mouse liver LPO values.
Influence of the wine capsule to Mouse whole blood SOD activity 5. liver protection is dispelled
Each experimental mice whole blood SOD values of table 6
Note:Compared with blank control group, * represents P<0.05
Test result indicates that, compared with blank control group, remaining each experimental mice whole blood SOD value is reduced, with the positive
Control group is compared, and the SOD values of administration group are significantly increased, and illustrates that liver protection wine capsule of dispelling can effectively improve the SOD of Mouse whole blood
Activity.
Each experimental mice liver organization pathological analysis
Fig. 1 is blank control group mouse liver organization chart;
Fig. 2 is positive controls mouse liver organization chart;
Fig. 3 is that liver protection is dispelled wine low dose group mouse liver organization chart;
Fig. 4 is that liver protection is dispelled wine middle dose group mouse liver organization chart;
Fig. 5 is that liver protection is dispelled wine high dose group mouse liver organization chart.
Referring to Fig. 1-Fig. 5, result above shows, after 30d is raised, and blank control group mouse, lobuli hepatis structure is normal, liver
Rope is arranged radially centered on central vein, and cell is in polyhedron, and monokaryon, accidental double-core, core is big and round, in cell
Centre;Positive controls mouse, liver cell obvious tumefaction, necrosis, kytoplasm is loose, and diffusivity balloon sample becomes, and kytoplasm apparent number is not
One, the fat drips that differ in size vacuole:Sobering-up liver-protecting capsule group mouse, lobuli hepatis structure is normal, and liver rope is using central vein in
The heart is arranged radially;High dose group mouse, lobuli hepatis structure is normal, and liver rope is arranged radially centered on central vein,
Cell is in polyhedron, and monokaryon, accidental double-core, core is big and round, positioned at cell center;Middle dose group and low dose group mouse, liver are thin
Born of the same parents' structure is normal, has slight haziness, swelling, fat to become, liver protection indicated above wine capsule of dispelling can be effectively protected Mouse Liver
Tissue.
2. dispelled the health-care food composition and its system of wine for liver protection the present invention is expanded on further by the following examples
Preparation Method:
Embodiment 1
The weight of liver-protecting capsule material component of the present invention is:
45 kilograms of sea-buckthorn
32 kilograms of oyster
22.8 kilograms of vitamin C pulvis
0.2 kilogram of vitamin B6
The preparation process of liver-protecting capsule of the present invention is as follows:
(1) preparation of sea-buckthorn:
Choose fresh, good, full maturity, in orange-yellow or salmon pink fructus hippophae, the branch that artificial removal is wherein mingled with
The impurity such as leaf soil rock, are cleaned up with clear water, wash away the silt adhered to thereon, worm's ovum etc., and the sea-buckthorn cleaned up is through repairing
Whole its carpopodium of removal flower base of a fruit etc., adds the purified water that 3 times of weight are 60 DEG C, equably sends into beater and carry out crushing and beating, beat
The screen-aperture of frame machine should be in 0.8 millimeter, and gained sea-buckthorn pulp carries out extruding with spiral juice extractor and takes juice and filter residue
Go, after filtering and concentrating, using vacuum and low temperature thousand dry methods of spraying, seabuckthorn fruit powder is made in extruding gained juice.
(2) preparation of oyster:
Fresh and alive oyster is taken, broken shell takes full oyster meat, directly or after washing be put into pressure cooker (pressure is 98kPa), plus etc.
Ratio pure water (weight ratio), boils about 30min under 98kPa pressure, recovers after normal pressure, is filtered under diminished pressure with filter paper, obtains milky white
Color extract solution.
Then, add equivalent pure water again into residue, about 30min is boiled, after being filtered, by this filtrate and original extraction
Liquid is mixed, then extract solution is carried out into vacuum (0.133-0.66kPa, 70-80 DEG C of temperature) distilled, obtain moisture for 67.34% it is viscous
Thick russet flow fluid, liquid color compared with before vacuum distillation is light.The concentrate is utilized into common spray dried form (wink
Between hot blast temperature be 180 DEG C, outlet temperature be 80 DEG C, speed of dripping be 30mL per minute) carry out wink-dry, obtain uniformly shallow
Yellow micro mist is stand-by.
(3) vitamin C pulvis:Commercially available pharmaceutical grade vitamin c powder;
(4) vitamin B6 pulvis:Commercially available pharmaceutical grade vitamin B6 powder
(5) prepared by semi-finished product:
Take 45 kilograms of seabuckthorn fruit powder, 32 kilograms of oyster, 22.8 kilograms of vitamin C, 0.2 kilogram of loading mixing machine of vitamin B6
It is interior, fully mix, the irradiation sterilization of cobalt 1 (5KGY) after pack, thousand dry preservations.
(6) prepared by finished product:
No. 1 mechanical irrigation capsule shell of selection, 0.3 gram/filling with capsule filling machine, then using aluminum-plastic packaged, it is aluminum-plastic packaged
Plate, with being fitted into polybag, finally adds outer packing, finished product is made with small desiccant bag.
With reference to the explanation of the invention disclosed here and practice, other embodiment of the invention is for those skilled in the art
It all will be readily apparent and understand.Illustrate and embodiment is to be considered only as exemplary, of the invention true scope and purport is equal
It is defined in the claims.
Claims (10)
1. a kind of health-care food composition for wine of being dispelled for liver protection, includes the raw material of following parts by weight:Oyster:25-40 parts, sand
Spine:40-60 parts, vitamin C:20-30 parts, vitamin B6:0.01-1.5 parts.
2. the health-care food composition of wine according to claim 1 of being dispelled for liver protection, it is characterised in that:The oyster is
30-35 parts;The sea-buckthorn is 42-58 parts;The vitamin C is 22-28 parts, vitamin B6 is 0.01-1.5 parts.
3. the health-care food composition of wine according to claim 1 of being dispelled for liver protection, it is characterised in that:The oyster is 32
Part;The sea-buckthorn is 45 parts;The vitamin C is 22.8 parts;Vitamin B6 is 0.2 part.
The preparation method of the health-care food composition of wine 4. a kind of liver protection is dispelled, comprises the following steps:
(1) fructus hippophae is gone into the removal of impurity, cleaned up, removed its carpopodium flower base of a fruit, add water, crushing and beating, by gained fructus hippophae
Slurry extruding takes juice and filters off residue, and gained juice is dried after filtering and concentrating, and seabuckthorn fruit powder is made;
(2) fresh and alive oyster is taken, broken shell takes full oyster meat, directly or is put into pressure cooker and boils after washing, filter, obtain milky and carry
Liquid is taken, then, adds equivalent pure water again into residue, about 30min is boiled, after being filtered, by this filtrate and original extract solution
Mixing, then extract solution is evaporated in vacuo, the sticky russet flow fluid that moisture is 67.34% is obtained, the concentrate is carried out
Spray drying, obtains uniformly light yellow micro mist;
(3) vitamin C is taken;
(4) vitamin B6 is taken;
(5) above-mentioned four kinds of raw materials are loaded in mixing machine according to the above ratio, fully mixed, the irradiation sterilization of cobalt 1 after pack, done
It is dry to preserve.
(6) prepared by finished product:
Select No. 1 mechanical irrigation preparation shell, it is filling with preparation bottle placer, 0.3 gram/again using aluminum-plastic packaged, plastic-aluminum packing plate with
Small desiccant bag finally adds outer packing, finished product is made with being fitted into polybag.
The preparation method of the health-care food composition of wine 5. liver protection according to claim 4 is dispelled, it is characterised in that:The step
Suddenly water described in (1) is purified water, and the weight of the purified water is 2-5 times of fructus hippophae;The temperature of the purified water is 50-70
℃。
The preparation method of the health-care food composition of wine 6. liver protection according to claim 4 is dispelled, it is characterised in that:The step
Suddenly water described in (1) is purified water, and the weight of the purified water is 3 times of fructus hippophae;The temperature of the purified water is 60 DEG C.
The preparation method of the health-care food composition of wine 7. the liver protection according to any one of claim 4-6 is dispelled, its feature
It is:Crushing and beating described in the step (1) uses the beater that screen-aperture is 0.6-1.0 millimeters;In the step (3)
Vitamin C to be powdered.
The preparation method of the health-care food composition of wine 8. the liver protection according to any one of claim 4-6 is dispelled, its feature
It is:Filter membrane used is 0.1-0.5 μm of filter membrane in the step (2);Milipore filter used is that cutoff amount is the super of 3500-6500
Filter membrane.
The preparation method of the health-care food composition of wine 9. liver protection according to claim 8 is dispelled, it is characterised in that:The step
Suddenly filter membrane used is 0.2 μm of filter membrane in (2);Milipore filter used is the milipore filter that cutoff amount is 5000.
The preparation method of the health-care food composition of wine 10. liver protection according to claim 7 is dispelled, it is characterised in that:It is described
Crushing and beating described in step (1) uses the beater that screen-aperture is 0.8 millimeter;Sieving sieve used in the step (2)
Son is 200 mesh.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710447203.9A CN107183716A (en) | 2017-06-14 | 2017-06-14 | A kind of liver protection is dispelled wine health-care food composition and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710447203.9A CN107183716A (en) | 2017-06-14 | 2017-06-14 | A kind of liver protection is dispelled wine health-care food composition and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN107183716A true CN107183716A (en) | 2017-09-22 |
Family
ID=59878395
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710447203.9A Withdrawn CN107183716A (en) | 2017-06-14 | 2017-06-14 | A kind of liver protection is dispelled wine health-care food composition and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107183716A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109043035A (en) * | 2018-08-08 | 2018-12-21 | 佳木斯大学 | A kind of instant hippophae rhamnoide nectar and preparation method thereof for the eyeshield that has effects that relieve the effect of alcohol |
CN110448659A (en) * | 2018-05-07 | 2019-11-15 | 新疆吉盛元沙棘生物科技有限公司 | Sea-buckthorn protect liver process for preparing buccal lozenge |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1623591A (en) * | 2003-12-04 | 2005-06-08 | 北京生物医药研究所 | Composition of pharmaceutical and preparation process thereof |
CN103535742A (en) * | 2013-09-27 | 2014-01-29 | 应博 | Anti-alcohol liver protection composition |
CN106102485A (en) * | 2013-11-29 | 2016-11-09 | 莫茨药物股份两合公司 | Alleviate the composition of the illeffects of alcohol |
-
2017
- 2017-06-14 CN CN201710447203.9A patent/CN107183716A/en not_active Withdrawn
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1623591A (en) * | 2003-12-04 | 2005-06-08 | 北京生物医药研究所 | Composition of pharmaceutical and preparation process thereof |
CN103535742A (en) * | 2013-09-27 | 2014-01-29 | 应博 | Anti-alcohol liver protection composition |
CN106102485A (en) * | 2013-11-29 | 2016-11-09 | 莫茨药物股份两合公司 | Alleviate the composition of the illeffects of alcohol |
Non-Patent Citations (2)
Title |
---|
代春美等: "海洋中药牡蛎的化学成分、药理活性及开发应用", 《天然产物研究与开发》 * |
刘广田: "《养肝就是养命》", 30 September 2016, 北京:中医古籍出版社 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110448659A (en) * | 2018-05-07 | 2019-11-15 | 新疆吉盛元沙棘生物科技有限公司 | Sea-buckthorn protect liver process for preparing buccal lozenge |
CN109043035A (en) * | 2018-08-08 | 2018-12-21 | 佳木斯大学 | A kind of instant hippophae rhamnoide nectar and preparation method thereof for the eyeshield that has effects that relieve the effect of alcohol |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Alok et al. | Herbal antioxidant in clinical practice: A review | |
CN106492110B (en) | Hangover alleviating composition, hangover alleviating and liver protecting preparation containing same and application of hangover alleviating and liver protecting preparation | |
US20180104299A1 (en) | Use of saffron and/or safranal and/or crocin and/or picrocrocin and/or derivatives thereof as a satiation agent for the treatment of obesity | |
Bumrungpert et al. | Effects of fenugreek, ginger, and turmeric supplementation on human milk volume and nutrient content in breastfeeding mothers: A randomized double-blind controlled trial | |
CN108135952A (en) | Flavonoid composition and its application method | |
ZA200502030B (en) | Composition comprising panax ginseng and paullinia cupana extracts | |
JP2013501778A (en) | HEALTH SUPPLEMENTAL, FEED, PHARMACEUTICAL COMPOSITION AND METHOD FOR PRODUCING THE SAME CONTAINING CHIASEED AND MACA | |
CN107455625A (en) | A kind of nutrient for plants beverage and its preparation technology with antifatigue weight losing function | |
CN101766274B (en) | Antioxidant functional food composition containing bamboo-leaves flavones | |
CN112274547A (en) | A composition containing herba Silybi Mariani extract and fructose-1, 6-diphosphate, and its application in protecting liver, relieving hangover, and relieving fatigue | |
CN105072913B (en) | Fruit cell and the method with such cell therapy disease is mass produced | |
US20190192601A1 (en) | Extracts of cyclanthera pedata and formulations and uses thereof | |
CN107183716A (en) | A kind of liver protection is dispelled wine health-care food composition and preparation method thereof | |
CN104306554B (en) | A kind of food, health products or pharmaceutical composition for treating gastric ulcer | |
CN103566282B (en) | A kind of Traditional Chinese medicine composition with anti-tumor effect and preparation method | |
EP1520584A1 (en) | Composition for the activation of the immune system | |
KR20040084168A (en) | Use of pinitol or chiro-inositol for preventing or treating liver diseases | |
CN110051817A (en) | A kind of Chinese traditional medicine composition and its application reducing uric acid | |
Bhardwaj et al. | Development of cucurbocitrin based nutraceutical formulation: A potential adjuvant herbal therapy in the management of hypertension | |
JP2006016330A (en) | Fat-burning accelerating agent | |
CN105963330B (en) | Miracle fruit preparation and its application | |
CN102366098A (en) | Supercritical propolis soft capsules and preparation method thereof | |
TW200803828A (en) | Cardiac dysfunction-ameliorating agent or cardiac function-maintaining agent | |
CN107638521A (en) | A kind of liver protection is dispelled the Chinese medicine composition and preparation method thereof of wine | |
CN105902601A (en) | Tamarindus indica linn. shell extract product and preparation method and application in reducing blood fat |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20170922 |
|
WW01 | Invention patent application withdrawn after publication |